Nuvasive, Inc. operates in the Surgical and medical instruments sector. NuVasive, Inc. (NuVasive) is a medical device company. NuVasive focuses on developing minimally disruptive surgical products and procedures for the spine. During the year ended December 31, 2010, it marketed product portfolio focused on applications for spine fusion surgery, including biologics. Its product offering includes a minimally disruptive surgical platform called Maximum Access Surgery (MAS), as well as offering of biologics, cervical and motion preservation products. NuVasive's spine surgery product line offerings include products for the thoracolumbar spine, the cervical spine, and a set of motion preservation product offerings under development. Its biologic product line offerings include allograft (donated human tissue), FormaGraft, a collagen synthetic product used to aid the fusion process, and Osteocel Plus, an allograft cellular matrix containing viable mesenchymal stem cells (MSCs). In October 2011, the Company acquired Impulse Monitoring, Inc. In our complete report available for purchase the company is compared to: Haemonetics Corporation, Merit Medical Systems, Inc. and Icu Medical, Inc..